Validation of the 2022 Clinical Diagnostic Criteria of Familial Hypercholesterolemia in Japan

CONCLUSION: The new JAS diagnostic criteria for FH have been noted to work well in terms of diagnosing definitive, probable, or possible FH patients. Thus, it is seen to be of great help in terms of risk discrimination.PMID:37967952 | DOI:10.5551/jat.64549
Source: Journal of Atherosclerosis and Thrombosis - Category: Cardiology Authors: Source Type: research